Australia markets open in 3 hours 14 minutes

Vaccitech plc (VACC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.0300+0.0300 (+0.75%)
At close: 04:00PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Vaccitech to Present at the H.C. Wainwright Global Investment Conference

    OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that the Company’s Chief Executive Officer, Bill Enright, and Chief Financial Officer, Georgy Egorov, will present at the H.C. Wainwright Global Investment Conference at 12:00 p.m. EDT on Tuesday, May 24, 2022. The conference will be held both in person in Miami and virt

  • Simply Wall St.

    Broker Revenue Forecasts For Vaccitech plc (NASDAQ:VACC) Are Surging Higher

    Shareholders in Vaccitech plc ( NASDAQ:VACC ) may be thrilled to learn that the analysts have just delivered a major...

  • GlobeNewswire

    Vaccitech Reports First Quarter 2022 Financial Results and Recent Corporate Developments

    OXFORD, United Kingdom, May 11, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC) today announced its financial results for the first quarter ended March 31, 2022, and provided an overview of the Company’s recent corporate developments. Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases, autoimmunity, and cancer. “We’ve already made solid progress acr